Biontech announces appointment of annemarie hanekamp to management board as chief commercial officer

Mainz, germany, march 20, 2024 (globe newswire) – biontech se (nasdaq: bntx, “biontech” or “the company”) announced today that the supervisory board has appointed annemarie hanekamp to the management board as chief commercial officer effective july 1, 2024. she will join biontech from novartis ag (“novartis”) and succeed sean marett in this role.
BNTX Ratings Summary
BNTX Quant Ranking